Premium
BioAtla Inc (BCAB)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071,... BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise Mecbotamab vedotin, Ozuriftabmab vedotin, BA3071, and Bispecific antibody programs. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.065301 | -10.6128717699 | 0.6153 | 0.6835 | 0.5311 | 2028782 | 0.61609041 | CS |
| 4 | -0.910001 | -62.3288356164 | 1.46 | 1.49 | 0.5311 | 1739041 | 0.71051624 | CS |
| 12 | -1.310001 | -70.4301612903 | 1.86 | 2.525 | 0.5311 | 1148006 | 1.31737093 | CS |
| 26 | -0.720001 | -56.692992126 | 1.27 | 2.525 | 0.5311 | 1156743 | 1.62169271 | CS |
| 52 | -1.930001 | -77.8226209677 | 2.48 | 4.02 | 0.5311 | 896080 | 1.90872812 | CS |
| 156 | -15.430001 | -96.558204005 | 15.98 | 16.49 | 0.5311 | 709851 | 3.75941318 | CS |
| 260 | -30.000001 | -98.1996759411 | 30.55 | 76.63 | 0.5311 | 588386 | 7.75632246 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
